DMD and Duchenne muscular dystrophy: We have previously reported the proof-of-concept studies testing a new chimeric cell line of the dystrophin expressing chimeric (DEC) cells, created by fusion of human myoblasts derived from duchenne muscular dystrophy (DMD) patients and normal healthy donors.